Empower Advisory Group »

Halozyme Therapeutics shares owned by Empower Advisory Group

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Empower Advisory Group from 13F filings

Historical chart of Empower Advisory Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Empower Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Empower Advisory Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $239k 5.9k 40.68
2023-12-31 $273k 7.4k 36.96
2023-09-30 $282k 7.4k 38.20
2023-06-30 $266k 7.4k 36.07
2023-03-31 $286k 7.4k 38.74

More positions owned by Empower Advisory Group

Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Gold Tr Ishares New (IAU)
Ishares Tr Usd Inv Grde Etf (USIG)
Vanguard Intl Equity Index F Glb Ex Us Etf (VNQI)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Vanguard Scottsdale Fds Long Term Treas (VGLT)
Vanguard Intl Equity Index F Ftse Smcap Etf (VSS)
Ishares Tr Esg Aw Msci Eafe (ESGD)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Empower Advisory Group

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Snyder Capital Management
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
TD Asset Management
Jennifer Ranahan
Arrowpoint Asset Management
Northern Trust
Thrivent Financial for Lutherans
Bank of America Corporation
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Halozyme Therapeutics